Non-clinical services for development of interventional agents for infectious diseases
Ended Awarded Last action
- Contract number
- 75N93021F00001
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $257,053
Award facts
- Contract value 100% obligated
- $257,053.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $257,053 |
About this award
This is a federal contract award to Sri International, a non-profit research and development institute, by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services. The $257,053 delivery order contract is for non-clinical services to support the development of interventional agents for infectious diseases. This award is part of a larger NIAID indefinite delivery vehicle contract for nonclinical services. The contract does not have a set-aside designation, likely due to Sri International's size and non-profit status. As a large, multidisciplinary research organization, Sri International frequently serves as a prime contractor and partner on federal research and development projects across numerous government agencies and scientific domains, including biomedical sciences, defense technologies, and aerospace.
Quick answers
Who was awarded contract 75N93021F00001?
75N93021F00001 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 4, 2021.
How much is contract 75N93021F00001 worth?
The government has obligated $257,053 on 75N93021F00001.
Is contract 75N93021F00001 an order under another contract?
Yes. 75N93021F00001 is a delivery order under 75N93018D00001, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93021F00001 competed?
The extent of competition for 75N93021F00001 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award